Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Appointed director
Quarterly results
Director departure
CC transcript
|
|
CRYO CELL INTERNATIONAL INC (CCEL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
8-K
| Quarterly results |
| 08/25/2023 |
8-K
| Other Events Interactive Data |
| 03/09/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 12/29/2022 |
8-K
| Quarterly results |
| 10/05/2022 |
8-K
| Quarterly results |
| 08/23/2022 |
8-K
| Other Events Interactive Data |
| 07/22/2022 |
8-K
| Quarterly results |
| 03/16/2022 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"PURCHASE AGREEMENTBETWEEN",
"CORD BLOOD BANKING LEADER CRYO-CELL ANNOUNCES EXTRAVAULT BIOREPOSITORY SERVICE OLDSMAR, FL – March 16, 2022 – Cryo-Cell International, Inc. , the world’s first private cord blood bank to separate and store stem cells in 1992, announces it has entered into a purchase contract, with the closing subject to customary conditions, for a newly constructed, 56,000 sq ft facility located in the Regional Commerce Center within the Research Triangle, NC. We anticipate this facility will expand Cryo-Cell’s cryopreservation and cold storage business by introducing a new service, ExtraVault . With over 30 years of experience in handling biological specimens for both research and clinical use, Cryo-Cell intends to leverage this expertise and offer these biorepository services to biopharmaceutical compani..." |
|
| 02/24/2022 |
8-K
| Quarterly results |
| 01/25/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 12/15/2021 |
8-K
| Quarterly results |
| 10/25/2021 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 10/15/2021 |
8-K
| Quarterly results |
| 09/22/2021 |
8-K
| Quarterly results |
| 08/04/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/19/2021 |
8-K
| Quarterly results |
| 06/30/2021 |
8-K
| Appointed a new director |
| 04/16/2021 |
8-K
| Quarterly results |
| 02/25/2021 |
8-K
| Quarterly results |
| 12/10/2020 |
8-K
| Entry into a Material Definitive Agreement |
| 10/19/2020 |
8-K
| Quarterly results |
| 09/23/2020 |
8-K
| Quarterly results |
| 09/08/2020 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement |
| 08/11/2020 |
8-K
| Quarterly results |
| 07/13/2020 |
8-K
| Quarterly results |
| 06/11/2020 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits|
Docs:
|
"SIGNATURE",
"Patent Option Agreement, between Duke University and Cryo-Cell International, Inc",
"CORD BLOOD BANKING LEADER CRYO-CELL ENTERS INTO PATENT OPTION AGREEMENT WITH DUKE UNIVERSITY OLDSMAR, FL - June 11, 2020 - Cryo-Cell International, Inc. , the world's first private cord blood bank to separate and store stem cells in 1992, announced that effective June 9, 2020, the Company has entered into a patent option agreement with Duke University. The six-month exclusive option agreement gives Cryo-Cell an option to obtain a license to manufacture and sell products based on Dr. Joanne Kurtzberg's patents. Please see the Company's Form 8-K filed with the Securities and Exchange Commission on June 11, 2020 for more details. David Portnoy, Chairman of the Board and Co-CEO, said, “Cryo-Cell is honored to have entered into this option agreement with Dr. Kurtzberg and Duke University and be..." |
|
| 05/06/2020 |
8-K
| Quarterly results |
| 03/02/2020 |
8-K
| Quarterly results |
| 11/27/2019 |
8-K
| Quarterly results |
| 10/17/2019 |
8-K
| Quarterly results|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report : October 15, 2019 CRYO CELL International, Inc. Delaware 000-23386 22-3023093 700 Brooker Creek Boulevard, Oldsmar, Florida 34677 Registrant's telephone number, including area code: 749-2100 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act )...",
"CORD BLOOD BANKING LEADER CRYO-CELL REPORTS FISCAL THIRD QUARTER 2019 FINANCIAL RESULTS OLDSMAR, FL - October 15, 2019 - Cryo-Cell International, Inc. , the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2019. Financial Results" |
|
| 10/08/2019 |
8-K
| Quarterly results |
| 10/02/2019 |
8-K
| Quarterly results |
| 07/25/2019 |
8-K
| Quarterly results |
| 04/16/2019 |
8-K
| Quarterly results |
|
|
|